# SARC018: A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma

> **NCT02303262** · PHASE2 · COMPLETED · sponsor: **Sarcoma Alliance for Research through Collaboration** · enrollment: 20 (actual)

## Conditions studied

- Metastatic Leiomyosarcoma

## Interventions

- **DRUG:** Mocetinostat
- **DRUG:** Gemcitabine

## Key facts

- **NCT ID:** NCT02303262
- **Lead sponsor:** Sarcoma Alliance for Research through Collaboration
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-12
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02303262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02303262, "SARC018: A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02303262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*